151 related articles for article (PubMed ID: 30892430)
1. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease.
Xiong G; Jiang X; Song T
Rev Assoc Med Bras (1992); 2019 Feb; 65(2):110-117. PubMed ID: 30892430
[TBL] [Abstract][Full Text] [Related]
2. Transforming Growth Factor β1 (TGF-β1) Appears to Promote Coronary Artery Disease by Upregulating Sphingosine Kinase 1 (SPHK1) and Further Upregulating Its Downstream TIMP-1.
Wang S; Zhang Q; Wang Y; You B; Meng Q; Zhang S; Li X; Ge Z
Med Sci Monit; 2018 Oct; 24():7322-7328. PubMed ID: 30317247
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of lncRNA-ATB by Transforming Growth Factor β1 (TGF-β1) Promotes Migration and Invasion of Papillary Thyroid Carcinoma Cells.
Cui M; Chang Y; Du W; Liu S; Qi J; Luo R; Luo S
Med Sci Monit; 2018 Jul; 24():5152-5158. PubMed ID: 30042377
[TBL] [Abstract][Full Text] [Related]
4. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.
Yin Q; Wu A; Liu M
Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258
[TBL] [Abstract][Full Text] [Related]
5. Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population.
Zhang Z; Gao W; Long QQ; Zhang J; Li YF; Liu DC; Yan JJ; Yang ZJ; Wang LS
Sci Rep; 2017 Aug; 7(1):7491. PubMed ID: 28790415
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
Dong X; Wang J; Li T; Xu YP; Li SY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ANCR is positively correlated with transforming growth factor-β1 in patients with osteoarthritis.
Li Q; Zhang Z; Guo S; Tang G; Lu W; Qi X
J Cell Biochem; 2019 Sep; 120(9):14226-14232. PubMed ID: 31074173
[TBL] [Abstract][Full Text] [Related]
8. LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-β pathway.
Ma J; Xue M
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061183
[No Abstract] [Full Text] [Related]
9. LncRNA PlncRNA-1 participates in rheumatoid arthritis by regulating transforming growth factor β1.
Wang Y; Li G; Guo W; Ji B; Aisikeerbayi A; Boratibai Y; Cao L
Autoimmunity; 2020 Sep; 53(6):297-302. PubMed ID: 32543888
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA of Myocardial Infarction Associated Transcript (LncRNA-MIAT) Promotes Diabetic Retinopathy by Upregulating Transforming Growth Factor-β1 (TGF-β1) Signaling.
Li Q; Pang L; Yang W; Liu X; Su G; Dong Y
Med Sci Monit; 2018 Dec; 24():9497-9503. PubMed ID: 30595603
[TBL] [Abstract][Full Text] [Related]
11. Expression of a Novel Long Noncoding RNA (lncRNA), GASL1, is Downregulated in Patients with Intracranial Aneurysms and Regulates the Proliferation of Vascular Smooth Muscle Cells In Vitro.
Man H; Bi W
Med Sci Monit; 2019 Feb; 25():1133-1139. PubMed ID: 30742604
[TBL] [Abstract][Full Text] [Related]
12. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.
Xu Y; Shao B
J Clin Lab Anal; 2018 Sep; 32(7):e22452. PubMed ID: 29744951
[TBL] [Abstract][Full Text] [Related]
13. A novel plasma lncRNA ENST00000416361 is upregulated in coronary artery disease and is related to inflammation and lipid metabolism.
Li P; Yan X; Xu G; Pang Z; Weng J; Yin J; Li M; Yu L; Chen Q; Sun K
Mol Med Rep; 2020 Jun; 21(6):2375-2384. PubMed ID: 32323776
[TBL] [Abstract][Full Text] [Related]
14. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
[TBL] [Abstract][Full Text] [Related]
15. Identification of a peripheral blood long non-coding RNA (Upperhand) as a potential diagnostic marker of coronary artery disease.
Li X; Zhao Z; Gao C; Rao L; Hao P; Jian D; Li W; Tang H; Li M
Cardiol J; 2018; 25(3):393-402. PubMed ID: 29168540
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity.
Rasa F; Naderi N; Eftekhar E; Mansoori E; Rahimzadeh M
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):522-529. PubMed ID: 29701163
[TBL] [Abstract][Full Text] [Related]
17. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
18. Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease.
Chen C; Lei W; Chen W; Zhong J; Gao X; Li B; Wang H; Huang C
BMC Cardiovasc Disord; 2014 Feb; 14():18. PubMed ID: 24533640
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PlncRNA-1 overexpression inhibits the growth of breast cancer by upregulating TGF-β1 and downregulating PHGDH.
Li Q; Gao H; Zhou S; Liao Y
Breast Cancer; 2018 Sep; 25(5):619-625. PubMed ID: 29626321
[TBL] [Abstract][Full Text] [Related]
20. Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression.
Yang H; Wang S; Wang F; Bai X; Ren J
Lupus; 2024 Jun; 33(7):675-684. PubMed ID: 38634475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
